BackActuate Therapeutics Overview

Actuate Therapeutics Total Liabilities

Track Actuate Therapeutics's total liabilities ($400K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$404991.00
↓ 2.84% YoYΔ $-11831.00 vs prior year quarter

Peer average

Loading

Actuate Therapeutics Total Liabilities History

Loading

Actuate Therapeutics vs. peers: Total Liabilities Comparison

Loading

Actuate Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Actuate Therapeutics (ACTU) FAQ

Actuate Therapeutics (ACTU) currently reports a total liabilities of $400K as of March 2026. That compares with $420K in the prior-year period — down 2.8% year over year. Use the charts on this page to explore Actuate Therapeutics's total liabilities history and peer comparisons.

Actuate Therapeutics's total liabilities decreased from $420K to $400K — a 2.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Actuate Therapeutics reported $400K in total liabilities as of March 2026. That compares with $420K in the prior-year period — down 2.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $400K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Actuate Therapeutics, and consider following ACTU for alerts when major investors trade the stock.